Literature DB >> 1491551

Cervico-thoraco-abdominal (3-field) lymph node dissection for carcinoma in the thoracic esophagus.

H Fujita1, T Kakegawa, H Yamana, I Shima, H Rikitake, M Hyodo, T Yokoyama, T Fujii, U Toh, S Tsugane.   

Abstract

The efficacy of an extended radical lymph node dissection for carcinoma in the thoracic esophagus is controversial. Results of a multivariate analysis using clinical data from 127 cases collected from 1982 to 1988 are reported. Twenty-seven of these patients underwent an extended radical (cervico-thoraco-abdominal: 3 fields) lymph node dissection which was recently developed in Japan, while others underwent a standard (thoraco-abdominal: 2 fields) lymph node dissection. They all had a locally-curative resection of the tumor through a right thoracotomy. In this study, 13 factors commonly affecting prognosis were examined: sex, age, cancer location, tumor length, radiographic type, depth of invasion, lymph node metastasis, tumor differentiation, postoperative radiotherapy, chemotherapy, operative risk, postoperative complications, and 3-field or 2-field dissection. Based on the survival-rate curves using Kaplan-Meier's statistics, the 3-field dissection was superior to the 2-field dissection. Moreover, when other prognostic factors were adjusted using Cox's proportional hazards general linear model, the same result was obtained from survival-rate curves. From this analysis, it can be concluded that a 3-field dissection is a better approach for management of carcinoma in the thoracic esophagus.

Entities:  

Mesh:

Year:  1992        PMID: 1491551     DOI: 10.2739/kurumemedj.39.167

Source DB:  PubMed          Journal:  Kurume Med J        ISSN: 0023-5679


  4 in total

Review 1.  Cervical lymph node metastases from remote primary tumor sites.

Authors:  Fernando López; Juan P Rodrigo; Carl E Silver; Missak Haigentz; Justin A Bishop; Primož Strojan; Dana M Hartl; Patrick J Bradley; William M Mendenhall; Carlos Suárez; Robert P Takes; Marc Hamoir; K Thomas Robbins; Ashok R Shaha; Jochen A Werner; Alessandra Rinaldo; Alfio Ferlito
Journal:  Head Neck       Date:  2015-12-29       Impact factor: 3.147

Review 2.  Three-field lymph node dissection in treating the esophageal cancer.

Authors:  Qi-Xin Shang; Long-Qi Chen; Wei-Peng Hu; Han-Yu Deng; Yong Yuan; Jie Cai
Journal:  J Thorac Dis       Date:  2016-10       Impact factor: 2.895

Review 3.  Three-field vs two-field lymph node dissection for esophageal cancer: a meta-analysis.

Authors:  Guo-Wei Ma; Dong-Rong Situ; Qi-Long Ma; Hao Long; Lan-Jun Zhang; Peng Lin; Tie-Hua Rong
Journal:  World J Gastroenterol       Date:  2014-12-21       Impact factor: 5.742

4.  Mortality and morbidity rates, postoperative course, quality of life, and prognosis after extended radical lymphadenectomy for esophageal cancer. Comparison of three-field lymphadenectomy with two-field lymphadenectomy.

Authors:  H Fujita; T Kakegawa; H Yamana; I Shima; Y Toh; Y Tomita; T Fujii; K Yamasaki; K Higaki; T Noake
Journal:  Ann Surg       Date:  1995-11       Impact factor: 12.969

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.